SARS-CoV-2’s potential for neuroinvasion and primary emerging neurologic features
Cleveland Clinic IND application is first approved in Parkinson’s and Alzheimer’s
Third annual report shows shift toward prevention studies, disease-modifying therapies
Will support preclinical work in parallel with ongoing human trial
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Insights on first-ever exercise endorsement and more
Advertisement
Advertisement